Image de couverture de livre

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yifu Shi, Xinyuan Wei, Fengnian Zhao, Junru Chen, Guangxi Sun, Xingming Zhang, Jiayu Liang, Xu Hu, Pengfei Shen, Zhenhua Liu, Ling Nie, Ni Chen, Jinge Zhao, Hao Zeng
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	The Prostate
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Limitations and Implications: Revisiting the Clinical Relevance of Ductal Features in Abiraterone‐Treated Prostate Cancer
par: Wenjing Xie, et autres
Publié: (2026)

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67
par: Fengnian Zhao, et autres
Publié: (2024)

Prognostic Impact of Initial Prostate Specific Antigen Half‐Life After Abiraterone Acetate in High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: Who May Need Triplet Therapy?
par: Kotaro Suzuki, et autres
Publié: (2026)

Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration‐Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate
par: Mitsuhisa Nishimoto, et autres
Publié: (2025)

Skeletal Muscle Loss During Treatment With Abiraterone in Patients With Metastatic Prostate Cancer
par: Eva Streckova, et autres
Publié: (2025)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
par: Marta Victoria Lorenzo‐Sánchez, et autres
Publié: (2025)

Nectin‐4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study
par: Ezra G. Baraban, et autres
Publié: (2025)

Effects of Concurrent Administration of Spironolactone in Veterans with Metastatic Prostate Cancer Receiving Abiraterone: A Real‐World Retrospective Study
par: Erum Z. Whyne, et autres
Publié: (2024)

Real‐World Overall Survival Comparison of Enzalutamide and Abiraterone In First‐ and Second‐Line Setting of Metastatic Castration‐Resistant Prostate Cancer
par: András Horváth, et autres
Publié: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
par: Cameron J. Britton, et autres
Publié: (2025)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
par: Christian Andrés Martínez Osorio, et autres
Publié: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
par: Tatsuya Shimomura, et autres
Publié: (2026)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
par: Haotian Chen, et autres
Publié: (2025)

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density
par: Shengyi Chen, et autres
Publié: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
par: Elizabeth Robinson, et autres
Publié: (2025)

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone‐Sensitive Prostate Cancer Treated With First‐Line ARPI Therapy
par: Takeshi Tsutsumi, et autres
Publié: (2026)

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
par: Y. M. Yáñez‐Castillo, et autres
Publié: (2025)

Immunohistochemical Detection of CD147 Expression in Adenocarcinoma of the Prostate: A Case‐Control Study
par: Sara Suliman, et autres
Publié: (2024)

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
par: Emily Chan, et autres
Publié: (2025)

The Efficacy of Transperineal Drainage for Treating Prostatic Abscess: A Comparative Analysis Against Conservative Management
par: Sung Goo Yoon, et autres
Publié: (2025)

Comments on the Study “Adapting the Bellmunt Risk Score for Prognostic Stratification in Metastatic Castration‐Sensitive Prostate Cancer”
par: Xian Wen
Publié: (2026)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
par: Amr M. Lotfy, et autres
Publié: (2026)

Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients
par: Cem Onal, et autres
Publié: (2024)

Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer
par: Ali Fuat Gürbüz, et autres
Publié: (2026)

Prognostic Nutritional Index as a Biomarker in Metastatic Hormone‐Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization
par: Muhammet Bekir Hacioglu, et autres
Publié: (2025)

Discovering the Prostate: Notes on History and Historiography
par: Diederik F. Janssen
Publié: (2025)

Evidence and Rationale for Prostate Cancer Screening
par: Takeshi Takahashi
Publié: (2025)

Spatial Characteristics of Intraductal Carcinoma of the Prostate
par: Rodolphe Dupuis, et autres
Publié: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
par: Charly Bâcle, et autres
Publié: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
par: Giuston Mendoza‐Chuctaya, et autres
Publié: (2025)

Mechanical‐Inflammatory Protection: Explaining Favorable Oncological Outcomes in Large Prostates
par: Yu‐Hsiang Lin, et autres
Publié: (2025)

Relationship Between Radiation Therapy and Fecal Incontinence in Patients Treated for Localized Prostate Cancer: Results of the French ICONES Study
par: Yazid Belkacemi, et autres
Publié: (2025)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
par: Ahmed Yehia Abdelaziz, et autres
Publié: (2024)

Zinc Ameliorates Inflammation and Sperm Parameters in Rats With Experimental Autoimmune Prostatitis
par: Ziqi Chen, et autres
Publié: (2025)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
par: Trevor C. Hunt, et autres
Publié: (2025)

Mycobacterium Tuberculosis: The Hidden Bacteria in Chronic Prostatitis
par: André Avarese Figueiredo, et autres
Publié: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
par: Hannu Koistinen, et autres
Publié: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
par: Sheila Jonnatan, et autres
Publié: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
par: Andrea K. Miyahira, et autres
Publié: (2024)

Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive Technique
par: Andrea Romei, et autres
Publié: (2025)